List view / Grid view

News

 

25 March 2011 Bristol Myers Squibb logo

FDA Approves YERVOY™ (ipilimumab)

25 March 2011 | By Bristol-Myers Squibb Company

For the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer...

Send this to a friend